Mohamad Shebley

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Clinical and translational science

Clinical pharmacokinetics

Journal of clinical pharmacology

Clinical pharmacology and therapeutics

AbbVie Inc

University of Michigan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Inc May 28 2007

United States

Director :: Clinical Pharmacology and Pharmacometrics

Education History

University of Michigan Sep 01 2002 - May 01 2007

United States

PHD :: Pharmacology

Publications

Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Atogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Atogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Ubrogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Ubrogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Iris K Minichmayr, Mohamad Shebley, Piet H van der Graaf, Karthik Venkatakrishnan
Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine. Clinical pharmacology and therapeutics 116 (3) (2024)
Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Ubrogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Ramesh Boinpally, Mohamad Shebley, Joel M Trugman
Atogepant: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Scott Marshall, Malidi Ahamadi, Jenny Chien, Daisuke Iwata, Pavel Farkas, Augusto Filipe, Nicolas Frey, Erin Greene, Norisuke Kawai, Jian Li, Joerg Lippert, Flora T Musuamba, Efthymios Manolis, Mark C Peterson, Sarem Sarem, Mohamad Shebley, Million Tegenge, Chia-Hsun Tsai, Chien-Lung Tu, Yasuto Otsubo, Jiawei Wei, Lucia Zhang, Hao Zhu, Kristin E Karlsson
Model-Informed Drug Development: Steps Toward Harmonized Guidance. Clinical pharmacology and therapeutics (2023)
Mohamad Shebley, Stanley Wang, Izna Ali, Preethi Krishnan, Rakesh Tripathi, Joseph Michael Reardon, John Cafardi, Galia Rahav, Yoseph Caraco, Jihad Slim, Fadi Al Akhrass, Mengjia Yu, Yiran Hu, Rosa De Abreu Ferreira, Negar N Alami
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19. Pharmacology research & perspectives 11 (1) (2022)
Denise Beck, Insa Winzenborg, Wei Gao, Nael M Mostafa, Stephanie E Chiuve, Charlotte Owens, Mohamad Shebley
Interdisciplinary model-informed drug development for extending duration of elagolix treatment in patients with uterine fibroids. British journal of clinical pharmacology 88 (12) (2022)
Mohamad Shebley, Stanley Wang, Izna Ali, Preethi Krishnan, Rakesh Tripathi, Joseph Michael Reardon, John Cafardi, Galia Rahav, Yoseph Caraco, Jihad Slim, Fadi Al Akhrass, Mengjia Yu, Yiran Hu, Rosa De Abreu Ferreira, Negar N Alami
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19. Pharmacology research & perspectives 11 (1) (2022)
Denise Beck, Insa Winzenborg, Mohan Liu, Jacob F Degner, Nael M Mostafa, Peter Noertersheuser, Mohamad Shebley
Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids. Clinical pharmacokinetics (2021)
Manoj S Chiney, Juki W Ng, John P Gibbs, Mohamad Shebley
Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 59 (5) (2021)
Mohamad Shebley, Akshanth R Polepally, Ahmed Nader, Juki W Ng, Insa Winzenborg, Cheri E Klein, Peter Noertersheuser, Megan A Gibbs, Nael M Mostafa
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. Clinical pharmacokinetics 59 (3) (2021)
Akshanth R Polepally, Juki W Ng, Ahmed Hamed Salem, Matthew B Dufek, Apurvasena Parikh, David C Carter, Kent Kamradt, Nael M Mostafa, Mohamad Shebley
Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist. Journal of clinical pharmacology 60 (12) (2020)
Mohamad Shebley, Rajeev M Menon, John P Gibbs, Nimita Dave, Su Y Kim, Patrick J Marroum
Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse. Journal of clinical pharmacology 59 (5) (2018)

Mohamad Shebley.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohamad Shebley